Pharma Reviews: Goldman downgrades Sun Pharma to 'sell', also cuts its target price

Mumbai: Goldman Sachs downgraded shares of India's largest pharmaceutical company Sun Pharmaceutical Industries to 'sell' from 'neutral' and cut ...
Read more: Goldman downgrades Sun Pharma to 'sell', also cuts its target price